Summit Hotel Properties, Inc. (INN-PF)
| Previous Close | 20.16 |
| Open | 20.02 |
| Bid | 19.97 x 800 |
| Ask | 20.52 x 1400 |
| Day's Range | 19.99 - 20.02 |
| 52 Week Range | 16.07 - 21.89 |
| Volume | |
| Avg. Volume | 5,560 |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.58 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | 1.47 (7.29%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
CNW GroupInnocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful pre-clinical treatment with a liposomal-CBD injection in a female donkey. Innocan's innovative therapy provided immediate noticeable pain relief and improved mobility.
Insider MonkeySummit Hotel Properties, Inc. (NYSE:INN) Q1 2024 Earnings Call Transcript
Summit Hotel Properties, Inc. (NYSE:INN) Q1 2024 Earnings Call Transcript May 2, 2024 Summit Hotel Properties, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Summit Hotel Properties’ 2024 First Quarter Earnings Conference Call. I will now […]
- GuruFocus.com
Summit Hotel Properties Inc (INN) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Discover how Summit Hotel Properties Inc achieved significant financial improvements and strategic milestones in the first quarter of 2024.
